These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 26514375)
1. Current preclinical small interfering RNA (siRNA)-based conjugate systems for RNA therapeutics. Lee SH; Kang YY; Jang HE; Mok H Adv Drug Deliv Rev; 2016 Sep; 104():78-92. PubMed ID: 26514375 [TBL] [Abstract][Full Text] [Related]
2. Molecularly engineered siRNA conjugates for tumor-targeted RNAi therapy. Lee JW; Choi J; Choi Y; Kim K; Yang Y; Kim SH; Yoon HY; Kwon IC J Control Release; 2022 Nov; 351():713-726. PubMed ID: 36152808 [TBL] [Abstract][Full Text] [Related]
3. Chemical and structural modifications of RNAi therapeutics. Ku SH; Jo SD; Lee YK; Kim K; Kim SH Adv Drug Deliv Rev; 2016 Sep; 104():16-28. PubMed ID: 26549145 [TBL] [Abstract][Full Text] [Related]
4. Small-interfering RNA (siRNA)-based functional micro- and nanostructures for efficient and selective gene silencing. Lee SH; Chung BH; Park TG; Nam YS; Mok H Acc Chem Res; 2012 Jul; 45(7):1014-25. PubMed ID: 22413937 [TBL] [Abstract][Full Text] [Related]
5. siRNA based drug design, quality, delivery and clinical translation. Subhan MA; Torchilin VP Nanomedicine; 2020 Oct; 29():102239. PubMed ID: 32544449 [TBL] [Abstract][Full Text] [Related]
6. Optimization of siRNA delivery to target sites: issues and future directions. Khalil IA; Yamada Y; Harashima H Expert Opin Drug Deliv; 2018 Nov; 15(11):1053-1065. PubMed ID: 30198792 [TBL] [Abstract][Full Text] [Related]
7. Bridging small interfering RNA with giant therapeutic outcomes using nanometric liposomes. Singh Y; Tomar S; Khan S; Meher JG; Pawar VK; Raval K; Sharma K; Singh PK; Chaurasia M; Surendar Reddy B; Chourasia MK J Control Release; 2015 Dec; 220(Pt A):368-387. PubMed ID: 26528900 [TBL] [Abstract][Full Text] [Related]
8. Strategies, design, and chemistry in siRNA delivery systems. Dong Y; Siegwart DJ; Anderson DG Adv Drug Deliv Rev; 2019 Apr; 144():133-147. PubMed ID: 31102606 [TBL] [Abstract][Full Text] [Related]
9. Generation of siRNA Nanosheets for Efficient RNA Interference. Kim H; Lee JS; Lee JB Sci Rep; 2016 Apr; 6():25146. PubMed ID: 27120975 [TBL] [Abstract][Full Text] [Related]
13. Cationic lipids and polymers mediated vectors for delivery of siRNA. Zhang S; Zhao B; Jiang H; Wang B; Ma B J Control Release; 2007 Oct; 123(1):1-10. PubMed ID: 17716771 [TBL] [Abstract][Full Text] [Related]
14. Emerging Approaches for Enabling RNAi Therapeutics. Mallick AM; Tripathi A; Mishra S; Mukherjee A; Dutta C; Chatterjee A; Sinha Roy R Chem Asian J; 2022 Aug; 17(16):e202200451. PubMed ID: 35689534 [TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances. Li SD; Huang L Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838 [TBL] [Abstract][Full Text] [Related]
16. siRNA Targeting and Treatment of Gastrointestinal Diseases. Chevalier R Clin Transl Sci; 2019 Nov; 12(6):573-585. PubMed ID: 31309709 [TBL] [Abstract][Full Text] [Related]
17. siRNA delivery: from lipids to cell-penetrating peptides and their mimics. Gooding M; Browne LP; Quinteiro FM; Selwood DL Chem Biol Drug Des; 2012 Dec; 80(6):787-809. PubMed ID: 22974319 [TBL] [Abstract][Full Text] [Related]
18. Delivery of siRNA to the Eye: Protocol for a Feasibility Study to Assess Novel Delivery System for Topical Delivery of siRNA Therapeutics to the Ocular Surface. Baran-Rachwalska P; Saffie-Siebert S; Moore CBT Methods Mol Biol; 2021; 2282():443-453. PubMed ID: 33928589 [TBL] [Abstract][Full Text] [Related]
19. Strategies for in vivo delivery of siRNAs: recent progress. Higuchi Y; Kawakami S; Hashida M BioDrugs; 2010 Jun; 24(3):195-205. PubMed ID: 20462284 [TBL] [Abstract][Full Text] [Related]